A notable advancement in glucose care is emerging with the introduction of tirzepatide at a dosage of 45mg. This updated formulation builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, and https://socialbuzzfeed.com/story6859678/groundbreaking-development-tirzepatide-45mg-for-diabetes-management